These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31223055)

  • 1. Native peptide mapping - A simple method to routinely monitor higher order structure changes and relation to functional activity.
    Degueldre M; Wielant A; Girot E; Burkitt W; O'Hara J; Debauve G; Gervais A; Jone C
    MAbs; 2019; 11(8):1391-1401. PubMed ID: 31223055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody higher order structure analysis by high throughput protein conformational array.
    Song Y; Yu D; Mayani M; Mussa N; Li ZJ
    MAbs; 2018 Apr; 10(3):397-405. PubMed ID: 29313446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy.
    Cao M; De Mel N; Shannon A; Prophet M; Wang C; Xu W; Niu B; Kim J; Albarghouthi M; Liu D; Meinke E; Lin S; Wang X; Wang J
    MAbs; 2019 Apr; 11(3):489-499. PubMed ID: 30786796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of critical chemical modifications and paratope mapping by size exclusion chromatography of stressed antibody-target complexes.
    Bondarenko P; Nichols AC; Xiao G; Shi RL; Chan PK; Dillon TM; Garces F; Semin DJ; Ricci MS
    MAbs; 2021; 13(1):1887629. PubMed ID: 33615991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a rapid RP-UHPLC-MS method for analysis of modifications in therapeutic monoclonal antibodies.
    Zhang B; Jeong J; Burgess B; Jazayri M; Tang Y; Taylor Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():172-181. PubMed ID: 27233581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.
    Mouchahoir T; Schiel JE
    Anal Bioanal Chem; 2018 Mar; 410(8):2111-2126. PubMed ID: 29411091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Characterization of Relationship Between Higher-Order Structure and FcRn Binding Affinity of Stress-Exposed Monoclonal Antibodies.
    Tsuchida D; Yamazaki K; Akashi S
    Pharm Res; 2016 Apr; 33(4):994-1002. PubMed ID: 26694753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of High Resolution NMR Methods to Probe the Impact of Chemical Modifications on Higher Order Structure of Monoclonal Antibodies in Relation to Antigen Binding.
    Majumder S; Saati A; Philip S; Liu LL; Stephens E; Rouse JC; Alphonse Ignatius A
    Pharm Res; 2019 Jul; 36(9):130. PubMed ID: 31264003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of standard accelerated stability conditions on antibody higher order structure as assessed by mass spectrometry.
    Kerr RA; Keire DA; Ye H
    MAbs; 2019 Jul; 11(5):930-941. PubMed ID: 30913973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional assessment of antibody oxidation by native mass spectrometry.
    Haberger M; Heidenreich AK; Schlothauer T; Hook M; Gassner J; Bomans K; Yegres M; Zwick A; Zimmermann B; Wegele H; Bonnington L; Reusch D; Bulau P
    MAbs; 2015; 7(5):891-900. PubMed ID: 26000623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of automated Wes system as an analytical and characterization tool to support monoclonal antibody drug product development.
    Wang J; Valdez A; Chen Y
    J Pharm Biomed Anal; 2017 May; 139():263-268. PubMed ID: 28069351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo.
    Kellie JF; Thomson AS; Chen S; Childs SL; Karlinsey MZ; Mai SH; White JR; Biddlecombe RA
    J Pharm Sci; 2019 Apr; 108(4):1415-1422. PubMed ID: 30465782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing in vivo dynamics of multiple quality attributes from a therapeutic IgG4 monoclonal antibody circulating in cynomolgus monkey.
    Li Y; Huang Y; Ferrant J; Lyubarskaya Y; Zhang YE; Li SP; Wu SL
    MAbs; 2016 Jul; 8(5):961-8. PubMed ID: 27030286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability.
    Schiel JE; Turner A; Mouchahoir T; Yandrofski K; Telikepalli S; King J; DeRose P; Ripple D; Phinney K
    Anal Bioanal Chem; 2018 Mar; 410(8):2127-2139. PubMed ID: 29411089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.
    Yan B; Steen S; Hambly D; Valliere-Douglass J; Vanden Bos T; Smallwood S; Yates Z; Arroll T; Han Y; Gadgil H; Latypov RF; Wallace A; Lim A; Kleemann GR; Wang W; Balland A
    J Pharm Sci; 2009 Oct; 98(10):3509-21. PubMed ID: 19475547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
    Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
    J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ID-MAM: A Validated Identity and Multi-Attribute Monitoring Method for Commercial Release and Stability Testing of a Bispecific Antibody.
    Evans AR; Hebert AS; Mulholland J; Lewis MJ; Hu P
    Anal Chem; 2021 Jul; 93(26):9166-9173. PubMed ID: 34161073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structure verification of a recombinant chimeric anti-CD20 IgG1 monoclonal antibody].
    Tao L; Rao CM; Gao K; Shi XC; Zhao Y; Wang JZ
    Yao Xue Xue Bao; 2010 Jun; 45(6):752-5. PubMed ID: 20939185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited proteolysis and peptide mapping for comparability of biopharmaceuticals: An evaluation of repeatability, intra-assay precision and capability to detect structural change.
    Perrin C; Burkitt W; Perraud X; O'Hara J; Jone C
    J Pharm Biomed Anal; 2016 May; 123():162-72. PubMed ID: 26918895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.